Immucor Inc. (BLUD) Tops Q3 EPS by 5c, Raised FY11 Guidance
Tweet
Share
E-mailGet Alerts BLUD Hot Sheet
Price: $26.81 --0%
Financial Fact:
Interest expense: -23.1M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Interest expense: -23.1M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Immucor Inc. (NASDAQ: BLUD) reported Q3 EPS of $0.32, $0.05 better than the analyst estimate of $0.27. Revenue for the quarter came in at $83.3 million versus the consensus estimate of $79.73 million.
Immucor Inc. raised its FY2011 EPS to $1.18-$1.20 from $1.08-$1.18, versus the consensus of $1.14. Immucor Inc. also raised its FY2011 revenue to $328-$330 million from $320-$322 million, versus the consensus of $327 million.
Immucor Inc. raised its FY2011 EPS to $1.18-$1.20 from $1.08-$1.18, versus the consensus of $1.14. Immucor Inc. also raised its FY2011 revenue to $328-$330 million from $320-$322 million, versus the consensus of $327 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- York Space Systems, Inc. (YSS) Reports Q2 Loss of $0.31 ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
